{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:42:47Z","timestamp":1783356167095,"version":"3.54.6"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,24]]},"DOI":"10.7759\/cureus.61015","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T18:14:52Z","timestamp":1716574492000},"source":"Crossref","is-referenced-by-count":2,"title":["Hemophagocytic Lymphohistiocytosis: A Case Report"],"prefix":"10.7759","author":[{"given":"Teresa","family":"Costa e Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Jorge Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Horta Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Sousa Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224123","article-title":"The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS)","volume":"82","author":"Shakoory B","year":"2023","unstructured":"Shakoory B, Geerlinks A, Wilejto M, et al.. The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS). Ann Rheum Dis. 2023, 82:1271-85. 10.1136\/ard-2023-224123","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-014-0274-1","article-title":"Hemophagocytic syndrome in children and adults","volume":"62","author":"Malinowska I","year":"2014","unstructured":"Malinowska I, Machaczka M, Popko K, Siwicka A, Salamonowicz M, Nasi\u0142owska-Adamska B. Hemophagocytic syndrome in children and adults. Arch Immunol Ther Exp (Warsz). 2014, 62:385-94. 10.1007\/s00005-014-0274-1","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21660","article-title":"Increased serum monocyte chemoattractant protein-1, macrophage inflammatory protein-1beta, and interleukin-8 concentrations in hemophagocytic lymphohistiocytosis","volume":"51","author":"Tamura K","year":"2008","unstructured":"Tamura K, Kanazawa T, Tsukada S, Kobayashi T, Kawamura M, Morikawa A. Increased serum monocyte chemoattractant protein-1, macrophage inflammatory protein-1beta, and interleukin-8 concentrations in hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008, 51:662-8. 10.1002\/pbc.21660","journal-title":"Pediatr Blood Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals M","year":"2014","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, L\u00f3pez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014, 383:1503-1516. 10.1016\/S0140-6736(13)61048-X","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e P","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, et al.. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019, 133:2465-77. 10.1182\/blood.2018894618","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.127","article-title":"Hemophagocytic lymphohistiocytosis (HLH) and related disorders","author":"Filipovich AH","year":"2009","unstructured":"Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program. 2009, 127-31. 10.1182\/asheducation-2009.1.127","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet L","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, et al.. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014, 66:2613-20. 10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12293","article-title":"Advances in understanding the pathogenesis of HLH","volume":"161","author":"Usmani GN","year":"2013","unstructured":"Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol. 2013, 161:609-22. 10.1111\/bjh.12293","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12255","article-title":"The dilemma of diagnosing hemophagocytic lymphohistiocytosis in sickle cell disease","volume":"12","author":"Sahu SK","year":"2020","unstructured":"Sahu SK, Agrawal A, Das P. The dilemma of diagnosing hemophagocytic lymphohistiocytosis in sickle cell disease. Cureus. 2020, 12:e12255. 10.7759\/cureus.12255","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e3181a1ae08","article-title":"Secondary hemophagocytic lymphohistiocytosis and severe sepsis\/ systemic inflammatory response syndrome\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation","volume":"10","author":"Castillo L","year":"2009","unstructured":"Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis\/ systemic inflammatory response syndrome\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009, 10:387-92. 10.1097\/PCC.0b013e3181a1ae08","journal-title":"Pediatr Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez379","article-title":"Haemophagocytic lymphohisticytosis-an underrecognized hyperinflammatory syndrome","volume":"58","author":"Hutchinson M","year":"2019","unstructured":"Hutchinson M, Tattersall RS, Manson JJ. Haemophagocytic lymphohisticytosis-an underrecognized hyperinflammatory syndrome. Rheumatology (Oxford). 2019, 58:vi23-30. 10.1093\/rheumatology\/kez379","journal-title":"Rheumatology (Oxford)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/1751143719893865","article-title":"Haemophagocytic lymphohistiocytosis in adult critical care","volume":"21","author":"Bauchmuller K","year":"2020","unstructured":"Bauchmuller K, Manson JJ, Tattersall R, Brown M, McNamara C, Singer M, Brett SJ. Haemophagocytic lymphohistiocytosis in adult critical care. J Intensive Care Soc. 2020, 21:256-68. 10.1177\/1751143719893865","journal-title":"J Intensive Care Soc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/10600280221134719","article-title":"A review of current and emerging therapeutic options for hemophagocytic lymphohistiocytosis","volume":"57","author":"Summerlin J","year":"2023","unstructured":"Summerlin J, Wells DA, Anderson MK, Halford Z. A review of current and emerging therapeutic options for hemophagocytic lymphohistiocytosis. Ann Pharmacother. 2023, 57:867-79. 10.1177\/10600280221134719","journal-title":"Ann Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/256515-hemophagocytic-lymphohistiocytosis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T18:14:56Z","timestamp":1716574496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/256515-hemophagocytic-lymphohistiocytosis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.61015","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,24]]}}}